Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB
about
Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cellsNeural tube defects, folate, and immune modulation.Population-level evidence for an autoimmune etiology of epilepsy.Anti-tumor mechanisms of valproate: a novel role for an old drug.Divide and conquer: functional segregation of synaptic inputs by astrocytic microdomains could alleviate paroxysmal activity following brain trauma.Interpreting clinical assays for histone deacetylase inhibitors.Valproic acid inhibits neural progenitor cell death by activation of NF-κB signaling pathway and up-regulation of Bcl-XL.Histone deacetylase inhibition enhances tissue plasminogen activator release capacity in atherosclerotic man.Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson's Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties.Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.Histone Deacetylases Inhibitors in the Treatment of Retinal Degenerative Diseases: Overview and PerspectivesMonocyte and microglial activation in patients with mood-stabilized bipolar disorder.Characteristics of Adult T-Cell Leukemia/Lymphoma Patients with Long Survival: Prognostic Significance of Skin Lesions and Possible Beneficial Role of Valproic Acid.Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application.Bipolar Disorder Associated microRNA, miR-1908-5p, Regulates the Expression of Genes Functioning in Neuronal Glutamatergic Synapses.The importance of toxoplasma gondii infection in diseases presenting with headaches. Headaches and aseptic meningitis may be manifestations of the Jarisch-Herxheimer reaction.Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-Cd40-stimulated blood in vitro.A safety assessment of tumor necrosis factor antagonists during pregnancy.Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies.Antiepileptic drugs and the immune system.HDACi: molecular mechanisms and therapeutic implications in the innate immune system.Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results.Emerging drugs for focal epilepsy.Inflammatory pathways of seizure disorders.Mood stabilizing drugs regulate transcription of immune, neuronal and metabolic pathway genes in Drosophila.The role and potential mechanism of resveratrol in the prevention and control of epilepsy.Different resuscitation strategies and novel pharmacologic treatment with valproic acid in traumatic brain injury.Regulation of Nitrogen Mustard-Induced Lung Macrophage Activation by Valproic Acid, a Histone Deacetylase Inhibitor.Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms.Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression.Valproic Acid Prevents Renal Dysfunction and Inflammation in the Ischemia-Reperfusion Injury Model.Anti-inflammatory Effects of Valproic Acid in a Rat Model of Renal Ischemia/Reperfusion Injury: Alteration in Cytokine Profile.Valproate ameliorates nitroglycerin-induced migraine in trigeminal nucleus caudalis in rats through inhibition of NF-кB.Inflammation and epilepsyIncreased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism.Valproic acid attenuates microgliosis in injured spinal cord and purinergic P2X4 receptor expression in activated microglia.Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties.Uncaria rhynchophylla and Rhynchophylline inhibit c-Jun N-terminal kinase phosphorylation and nuclear factor-kappaB activity in kainic acid-treated rats.Valproate-induced eosinophilia in children with epilepsy: role of interleukin-5.Octreotide ameliorates inflammation and apoptosis in acute and kindled murine PTZ paradigms.
P2860
Q28571669-1599549D-AB07-4A63-974D-9625BD92D3F3Q33739571-7B59B794-CC13-4676-8C92-A1C7D74B6A82Q34040405-B5C7E1AC-D064-4C48-8A89-519E57610981Q34147644-9B6DCCAA-E710-41CF-9B61-49B60E553573Q34565863-8EDFCAC2-2135-4355-A44C-5AC5DDDB836BQ35003657-C35F79CB-238E-4ECB-91E9-590C5DAF0A29Q35172584-26F5AE2E-9E5A-43A8-904E-B5708ED9E358Q35217250-190E6350-2FD2-4AB3-84A9-B612CC494B0AQ35623461-6296DF27-EE5C-4C24-BF58-2210E8ACABB9Q35661962-EF145D96-4A20-4DD6-A910-729CB1E3DCC3Q35744910-6A221583-C8FC-4FB0-97D2-D5D16FB60B58Q35772084-3A7E6DB0-5C21-4B6C-A33C-ECEEDEA45F76Q35833900-83DC9741-AD5C-4C5E-983B-A276B2A2666FQ37526428-40EE22FE-8311-4F27-8870-54156A337EF0Q37541356-D648860A-AE6B-425A-A8D2-233BBE16DDAEQ37633578-ADFE1E8E-F922-4E0D-B877-028B6D17EEA3Q37686605-57B77F91-BF99-4538-9D9F-05939D71207FQ37724349-1E23A65A-149F-4A68-9007-ED896C2534BAQ37820728-CFEB87E9-A7C7-4ABF-A76C-48CD74B03BCDQ37872031-871B68F8-ADC0-4298-81C5-DACB15318E44Q37956176-1ADD4DDA-05BC-4B8B-B18B-E33099A3F374Q38016227-FB2FDA44-61E3-46B9-9761-1C1B6CC61B57Q38062011-86C5B4D4-86B3-4D48-8221-BBA456BA700AQ38172740-ABDB60EF-31BE-448E-8E05-EA2AA887014BQ38451306-D2D9FE8C-14AE-4050-93FD-4978DE696118Q38617173-33153B11-38B0-4DAE-AB18-D684685BDBE3Q38652105-C48502BF-E4AA-44C4-9003-2DF13FB644AFQ38968676-A4694CFC-702B-467D-A283-0675F3B8FAB9Q38969134-3204EE85-642A-4A1A-9209-AD8F722CA5A5Q39013397-68CFE832-F04B-4B1C-8FE0-C3E894464995Q39754264-0B9F33F6-98C3-441A-9271-E6D9D9830C64Q40212416-61F0F7FA-84DB-4BC8-8C72-FD0440EB6738Q41108591-B78054BC-9BBD-4AD1-859A-40C1084C7FB2Q41867461-60CB188E-0522-4279-80C5-FCFC7C40D2EAQ44161291-32DD383C-BEF1-47DF-825E-D37053CA7A34Q44269727-5F3BD937-35D2-4BFA-9058-66D8FD09E343Q44674787-FE0427ED-4936-4B27-96E4-5ADE2DB51E5BQ45977196-2A9B2055-A4C2-4BDA-93DE-A4B4661124D6Q46407194-A3028B32-83C9-4B16-8E9E-9603676FDC83Q48489770-ECCD9F3C-CE25-4E4F-B3BC-3512BE2EE1B7
P2860
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB
@ast
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB
@en
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB
@nl
type
label
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB
@ast
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB
@en
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB
@nl
prefLabel
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB
@ast
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB
@en
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB
@nl
P2093
P3181
P1433
P1476
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB
@en
P2093
P304
P3181
P356
10.1016/S0006-8993(99)02439-7
P407
P577
2000-02-28T00:00:00Z